The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls
Open accessAbstract
A meta-analysis was conducted to explore the risk for cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia and age- and gender- or cohort-matched general population controls. Our literature search generated 203 relevant studies, of which 136 were included. The final dataset comprised 185,606 unique patients with schizophrenia, and 28 studies provided data for age- and gender-matched or cohort-matched general population controls (n=3,898,739). We found that multi-episode patients with schizophrenia were at increased risk for abdominal obesity (OR=4.43; CI=2.52-7.82; p<0.001), hypertension (OR=1.36; CI=1.21-1.53; p<0.001), low high-density lipoprotein cholesterol (OR=2.35; CI=1.78-3.10; p<0.001), hypertriglyceridemia (OR=2.73; CI=1.95-3.83; p<0.001), metabolic syndrome (OR=2.35; CI=1.68-3.29; p<0.001), and diabetes (OR=1.99; CI=1.55-2.54; p<0.001), compared to controls. Multi-episode patients with schizophrenia were also at increased risk, compared to first-episode (p<0.001) and drug-naïve (p<0.001) patients, for the above abnormalities, with the exception of hypertension and diabetes. Our data provide further evidence supporting WPA recommendations on screening, follow-up, health education and lifestyle changes in people with schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
The Metabolic Syndrome and Cardiovascular Risk
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
Self-citationSchizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
Gami, A. S., Witt, B. J., Howard, D. E., Erwin, P. J., Gami, L. A., Somers, V. K., & Montori, V. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.032 · Cited by 1,888
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
(2006) · Europe PMC (PubMed Central) · Cited by 1,299
Metabolic Syndrome and Risk of Cardiovascular Disease: A Meta-Analysis
Galassi, A., Reynolds, K., & He, J. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.031 · Cited by 1,207
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.156 · Cited by 1,145
McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., Meltzer, H. Y., Hsiao, J., Scott Stroup, T., & Lieberman, J. A. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.014 · Cited by 1,140
Kahn, R. S., Fleischhacker, W. W., Boter, H., Davidson, M., Vergouwe, Y., Keet, I. P., Gheorghe, M. D., Rybakowski, J. K., Galderisi, S., Libiger, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60486-9 · Cited by 1,088
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087
Mitchell, A. J., Vancampfort, D., Sweers, K., van Winkel, R., Yu, W., & De Hert, M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr148 · Cited by 1,082
Self-citationDE HERT, M., COHEN, D., BOBES, J., CETKOVICH‐BAKMAS, M., LEUCHT, S., NDETEI, D. M., NEWCOMER, J. W., UWAKWE, R., ASAI, I., MÖLLER, H., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00036.x · Cited by 870
Self-citationExcess mortality of schizophrenia: A meta-analysis
Brown, S. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.502 · Cited by 869
Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia
Ryan, M. C. M., Collins, P., & Thakore, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.284 · Cited by 828
Size of burden of schizophrenia and psychotic disorders
Rössler, W., Joachim Salize, H., van Os, J., & Riecher-Rössler, A. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.009 · Cited by 741
Twenty-five year mortality of a community cohort with schizophrenia
Brown, S., Kim, M., Mitchell, C., & Inskip, H. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067512 · Cited by 601
Prevalence and Correlates of Diabetes in National Schizophrenia Samples
Dixon, L., Weiden, P., Delahanty, J., Goldberg, R., Postrado, L., Lucksted, A., & Lehman, A. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033504 · Cited by 569
Mortality in a Cohort of Patients with Schizophrenia: A Record Linkage Study*
Newman, S. C., & Bland, R. C. (1991) · The Canadian Journal of Psychiatry · doi:10.1177/070674379103600401 · Cited by 371
Diabetes mellitus in schizophrenic patients
Mukherjee, S., Decina, P., Bocola, V., Saraceni, F., & Scapicchio, P. (1996) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(96)90054-1 · Cited by 368
Medical comorbidity in women and men with schizophrenia: A population-based controlled study
Carney, C. P., Jones, L., & Woolson, R. F. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00563.x · Cited by 343
Schizophrenia: A Life-shortening Disease
Allebeck, P. (1989) · Schizophrenia Bulletin · doi:10.1093/schbul/15.1.81 · Cited by 335
Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012) · Psychological Medicine · doi:10.1017/s003329171100105x · Cited by 332
Self-citationMitchell, A. J., Vancampfort, D., De Herdt, A., Yu, W., & De Hert, M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs082 · Cited by 327
Self-citationImpaired glucose tolerance in first‐episode drug‐naïve patients with schizophrenia
Spelman, L. M., Walsh, P. I., Sharifi, N., Collins, P., & Thakore, J. H. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02092.x · Cited by 318
Cohn, T., Prud'homme, D., Streiner, D., Kameh, H., & Remington, G. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404901106 · Cited by 254
De Hert, M., Schreurs, V., Sweers, K., Van Eyck, D., Hanssens, L., Šinko, S., Wampers, M., Scheen, A., Peuskens, J., & van Winkel, R. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.028 · Cited by 247
Self-citationExercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial
Scheewe, T. W., Backx, F. J. G., Takken, T., Jörg, F., van Strater, A. C. P., Kroes, A. G., Kahn, R. S., & Cahn, W. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12029 · Cited by 246
Metabolic Syndrome in Patients With Schizophrenia
Heiskanen, T., Niskanen, L., Lyytikäinen, R., Saarinen, P. I., & Hintikka, J. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0513 · Cited by 228
Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study
Osby, U. (2000) · BMJ · doi:10.1136/bmj.321.7259.483 · Cited by 220
De Hert, M., Vancampfort, D., Correll, C. U., Mercken, V., Peuskens, J., Sweers, K., van Winkel, R., & Mitchell, A. J. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.084665 · Cited by 217
Self-citationCorrell, C. U., Frederickson, A. M., Kane, J. M., & Manu, P. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0408 · Cited by 216
Self-citationNielsen, J., Skadhede, S., & Correll, C. U. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.78 · Cited by 207
Self-citationCardiovascular Disease in Patients With Schizophrenia in Saskatchewan, Canada
Curkendall, S. M., Mo, J., Glasser, D. B., Stang, M. R., & Jones, J. K. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0519 · Cited by 200
Capasso, R. M., Lineberry, T. W., Bostwick, J. M., Decker, P. A., & St. Sauver, J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.10.005 · Cited by 199
BOBES, J., ARANGO, C., ARANDA, P., CARMENA, R., GARCIAGARCIA, M., & REJAS, J. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.09.025 · Cited by 195
Birkenaes, A. B., Opjordsmoen, S., Brunborg, C., Engh, J. A., Jonsdottir, H., Ringen, P. A., Simonsen, C., Vaskinn, A., Birkeland, K. I., Friis, S., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0614 · Cited by 185
Bresee, L. C., Majumdar, S. R., Patten, S. B., & Johnson, J. A. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.016 · Cited by 177
Vancampfort, D., Probst, M., Scheewe, T., De Herdt, A., Sweers, K., Knapen, J., van Winkel, R., & De Hert, M. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2012.09.026 · Cited by 173
Self-citationPatel, J. K., Buckley, P. F., Woolson, S., Hamer, R. M., McEvoy, J. P., Perkins, D. O., Lieberman, J. A., & for the CAFE investigators (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.025 · Cited by 169
Prevalence of the Metabolic Syndrome Among Patients Receiving Clozapine
Lamberti, J. S., Olson, D., Crilly, J. F., Olivares, T., Williams, G. C., Tu, X., Tang, W., Wiener, K., Dvorin, S., & Dietz, M. B. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.7.1273 · Cited by 167
Vancampfort, D., Binder, M. D., Vansteenkiste, M., Herdt, A. D., Scheewe, T. W., Soundy, A., Stubbs, B., & Probst, M. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.10.004 · Cited by 164
Self-citationDe Hert, M., Yu, W., Detraux, J., Sweers, K., van Winkel, R., & Correll, C. U. (2012) · CNS Drugs · doi:10.2165/11634500-000000000-00000 · Cited by 161
Self-citationBeumer, W., Drexhage, R. C., De Wit, H., Versnel, M. A., Drexhage, H. A., & Cohen, D. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.04.001 · Cited by 161
Correll, C. U., Frederickson, A. M., Kane, J. M., & Manu, P. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00625.x · Cited by 158
Self-citationThe Metabolic Syndrome, Its Component Risk Factors, and Progression of Coronary Atherosclerosis
Bayturan, Ö., Tuzcu, E. M., Lavoie, A., Hu, T., Wolski, K., Schoenhagen, P., Kapadia, S., Nissen, S. E., & Nicholls, S. J. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.551 · Cited by 155
Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia
Vancampfort, D., Probst, M., Knapen, J., Carraro, A., & De Hert, M. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.03.046 · Cited by 149
Self-citationWu, R., Zhao, J., Liu, Z., Zhai, J., Guo, X., Guo, W., & Tang, J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0384-5 · Cited by 148
A 4-Fold Risk of Metabolic Syndrome in Patients With Schizophrenia
Saari, K. M., Lindeman, S. M., Viilo, K. M., Isohanni, M. K., Järvelin, M., Laurén, L., Savolainen, M. J., & Koponen, H. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0503 · Cited by 146
Vancampfort, D., Probst, M., Sweers, K., Maurissen, K., Knapen, J., & Hert, M. A. F. D. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01666.x · Cited by 145
Self-citationHigh prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia
Hägg, S., Lindblom, Y., Mjörndal, T., & Adolfsson, R. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000188215.84784.17 · Cited by 137
Vancampfort, D., Knapen, J., Probst, M., van Winkel, R., Deckx, S., Maurissen, K., Peuskens, J., & Binder, M. D. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.03.011 · Cited by 135
Self-citationMetabolic Risk Factors in Drug-Naive Patients With First-Episode Psychosis
Verma, S. K., Subramaniam, M., Liew, A., & Poon, L. Y. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04508 · Cited by 132
Saddichha, S., Manjunatha, N., Ameen, S., & Akhtar, S. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.004 · Cited by 131
Vancampfort, D., De Hert, M., Skjerven, L. H., Gyllensten, A. L., Parker, A., Mulders, N., Nyboe, L., Spencer, F., & Probst, M. (2012) · Disability and Rehabilitation · doi:10.3109/09638288.2011.587090 · Cited by 127
Self-citationFindings of a U.S. National Cardiometabolic Screening Program Among 10,084 Psychiatric Outpatients
Correll, C. U., Druss, B. G., Lombardo, I., O’Gorman, C., Harnett, J., Sanders, K. N., Alvir, J. M., & Cuffel, B. J. (2010) · Psychiatric Services · doi:10.1176/ps.2010.61.9.892 · Cited by 122
Self-citationMackin, P., Watkinson, H., & Young, A. H. (2005) · Diabetologia · doi:10.1007/s00125-004-1641-y · Cited by 115
Diabetes Mellitus and Impaired Glucose Tolerance in Patients with Schizophrenia
Subramaniam, M., Chong, S., & Pek, E. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800512 · Cited by 115
Prevalence of Metabolic Syndrome in Hispanic and Non-Hispanic Patients With Schizophrenia
Kato, M. M., Currier, B., Gomez, C. M., Hall, L., & Gonzalez-Blanco, M. (2004) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v06n0205 · Cited by 113
Sengupta, S. M., Parrilla-Escobar, M. A., Klink, R., Fathalli, F., Ng, Y. K., Stip, É., Baptista, T., MALLA, A. K., & Joober, R. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.02.013 · Cited by 110
The prevalence of metabolic syndrome among psychiatric inpatients in Brazil
Teixeira, P. J. R., & Rocha, F. L. (2007) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462007000400007 · Cited by 109
Suvisaari, J., Saarni, S. I., Perälä, J., Suvisaari, J. V. J., Härkänen, T., Lönnqvist, J. K., & Reunanen, A. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0711 · Cited by 109
Relationship between metabolic syndrome and cognition in patients with schizophrenia
Lindenmayer, J. P., Khan, A., Kaushik, S., Thanju, A., Praveen, R., Hoffman, L., Cherath, L., Valdez, G., & Wance, D. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.09.019 · Cited by 109
Mitchell, A. J., & Lord, O. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810382056 · Cited by 108
Self-citationEllingrod, V. L., Miller, D. D., Taylor, S. F., Moline, J., Holman, T. L., & Kerr, J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.09.030 · Cited by 107
Mai, Q., Holman, C. D. J., Sanfilippo, F. M., Emery, J. D., & Preen, D. B. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-118 · Cited by 106
Huang, M., Lu, M., Tsai, C. ‐., Chen, P. ‐., Chiu, C. ‐., Jian, D., Lin, K. M.-C., & Chen, C. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01401.x · Cited by 103
Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population
Pérez‐Iglesias, R., Mata, I. F., Pelayo‐Terán, J. M., Amado, J., García‐Unzueta, M. T., Berja, A., Martínez‐García, O., Vázquez‐Barquero, J. L., & Crespo‐Facorro, B. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.028 · Cited by 102
Mackin, P., Bishop, D. R., & Watkinson, H. (2007) · BMC Psychiatry · doi:10.1186/1471-244x-7-28 · Cited by 98
Review: Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?
Wildgust, H. J., & Beary, M. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810384639 · Cited by 97
Fleischhacker, W. W., SIU, C. O., Bodén, R., Pappadopulos, E. A., Karayal, O. N., Kahn, R. S., & the EUFEST study group (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001241 · Cited by 95
Mulder, H., Franke, B., van der, A. A. V. D. B., Arends, J., Wilmink, F. W., Scheffer, H., & Egberts, T. C. G. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3180a76dc0 · Cited by 94
Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia
Ramachandran, P., McCreadie, R. G., & Tirupati, S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.010 · Cited by 85
Ellingrod, V. L., Taylor, S. F., Dalack, G., Grove, T. B., Bly, M. J., Brook, R. D., Zöllner, S. K., & Pop-Busui, R. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182485888 · Cited by 84
Prevalence of metabolic syndrome among patients with schizophrenia in Japan
Sugawara, N., Yasui‐Furukori, N., Sato, Y., Umeda, T., Kishida, I., Yamashita, H., Saito, M., Furukori, H., Nakagami, T., Hatakeyama, M., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.08.030 · Cited by 84
HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With Schizophrenia
Mulder, H., Cohen, D., Scheffer, H., Wied, C. C. G., Arends, J., Wilmink, F. W., Franke, B., & Egberts, T. C. G. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181934462 · Cited by 82
Immune system and glucose metabolism interaction in schizophrenia: A chicken–egg dilemma
Steiner, J., Bernstein, H., Schiltz, K., Müller, U., Westphal, S., Drexhage, H. A., & Bogerts, B. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.09.016 · Cited by 81
Fan, X., Liu, E. Y., Freudenreich, O., Park, J. H., Liu, D., Wang, J., Yi, Z., GOFF, D. C., & Henderson, D. C. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.1028 · Cited by 80
Beary, M., Hodgson, R., & Wildgust, H. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112440512 · Cited by 79
L'Italien, G. J., & Casey, D. E. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1006 · Cited by 77
Kirkpatrick, B. W., Miller, B. J., García‐Rizo, C., Fernández-Egea, E., & Bernardo, M. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq058 · Cited by 76
van Winkel, R., van Os, J., Ćelić, I., Eyck, D. V., Wampers, M., Scheen, A. J., Peuskens, J., & Binder, M. D. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0817 · Cited by 75
Self-citationMortality in schizophrenia and related psychoses: data from two cohorts, 1875–1924 and 1994–2010
Healy, D., Le Noury, J., Harris, M., Butt, M., Linden, S., Whitaker, C., Zou, L., & Roberts, A. P. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001810 · Cited by 69
Suvisaari, J., Perälä, J., Saarni, S. I., Härkänen, T., Pirkola, S., Joukamaa, M., Koskinen, S., Lönnqvist, J., & Reunanen, A. (2008) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0762-y · Cited by 68
Bernardo, M., Cañas, F., Banegas, J. R., Casademont, J., Riesgo, Y., Varela, C., & On behalf of the RICAVA Study Group (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.07.010 · Cited by 67
Bai, Y. M., Chen, T. T., Yang, W., Chi, Y.-C., Lin, C.-C., Liou, Y., Wang, Y., Su, T., Chou, P., & Chen, J.-Y. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.014 · Cited by 67
Cardiometabolic effects of physical activity interventions for people with schizophrenia
Vancampfort, D., Knapen, J., Binder, M. D., van Winkel, R., Deckx, S., Maurissen, K., Peuskens, J., Simons, J., & Probst, M. (2009) · Physical Therapy Reviews · doi:10.1179/108331909x12540993898053 · Cited by 63
Self-citationAlméras, N., Després, J., Villeneuve, J., et al. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0417 · Cited by 62
Cardiovascular risk in a first-episode psychosis sample: A ‘critical period’ for prevention?
Phutane, V. H., Tek, C., Chwastiak, L., Ratliff, J. C., Ozyüksel, B., Woods, S. W., & Srihari, V. H. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2010.12.008 · Cited by 61
Miller, B. J., Mellor, A. L., & Buckley, P. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.08.016 · Cited by 60
Chien, I., Hsu, J., Lin, C.-H., Bih, S., Chou, Y., & Chou, P. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.04.003 · Cited by 59
Curtis, J., Henry, C., Watkins, A., Newall, H. D., Samaras, K., & Ward, P. B. (2011) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2011.00262.x · Cited by 58
Graham, K. A., Cho, H., Brownley, K. A., & Harp, J. B. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.12.476 · Cited by 58
Risselada, A., Vehof, J., Bruggeman, R., Wilffert, B., Cohen, D., Hadithy, A. F. A., Arends, J., & Mulder, H. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.66 · Cited by 57
Centorrino, F., Masters, G. A., Talamo, A., Baldessarini, R. J., & Öngür, D. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2257 · Cited by 55
Prediabetes in Patients Treated With Antipsychotic Drugs
Manu, P., Correll, C. U., van Winkel, R., Wampers, M., & Binder, M. D. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06822 · Cited by 54
Self-citationMetabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study
Srisurapanont, M., Likhitsathian, S., Boonyanaruthee, V., Charnsilp, C., & Jarusuraisin, N. (2007) · BMC Psychiatry · doi:10.1186/1471-244x-7-14 · Cited by 54
Prevalence of metabolic syndrome among patients with Schizophrenia in Palestine
Sweileh, W. M., Zyoud, S. H., Dalal, S. A., Ibwini, S., Sawalha, A. F., & Ali, I. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-235 · Cited by 54
Kurdyak, P. A., Vigod, S. N., Calzavara, A. J., & Wodchis, W. P. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.09.003 · Cited by 51
Saddichha, S., Ameen, S., & Akhtar, S. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.05.036 · Cited by 51
QTc interval in a sample of long-term schizophrenia inpatients
Ramos‐Ríos, R., Arrojo, M., Silva, E. P., Carballal-Calvo, F., Bouzón-Barreiro, J. L., Seoane-Prado, J., Codesido-Barcala, R., Crespí-Armenteros, A., Fernández-Pérez, R., López-Moríñigo, J.-D., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.09.041 · Cited by 51
Prevalence of Metabolic Syndrome Among Patients with Schizophrenia in Singapore
Lee, J., Nurjono, M., Wong, A., & Salim, A. (2012) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v41n10p457 · Cited by 50
Self-determination and stage of readiness to change physical activity behaviour in schizophrenia
Vancampfort, D., Vansteenkiste, M., Binder, M. D., Herdt, A. D., Soundy, A., Stubbs, B., Buys, R., & Probst, M. (2014) · Mental health and physical activity · doi:10.1016/j.mhpa.2014.06.003 · Cited by 49
Self-citationNuevo, R., Chatterji, S., Fraguas, D., Verdes, E., Naidoo, N., Arango, C., & Ayuso-Mateos, J. L. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06801 · Cited by 48
Okumura, Y., Ito, H., Kobayashi, M., Mayahara, K., Matsumoto, Y., & Hirakawa, J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.1061 · Cited by 48
Brunero, S., Lamont, S., & Fairbrother, G. (2009) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2008.06.007 · Cited by 48
The time-dependent change of insulin secretion in schizophrenic patients treated with olanzapine
Chiu, C.-C., Chen, C.-H., Chen, B.-Y., Yu, S.-H., & Lu, M. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.003 · Cited by 47
Lin, C.-C., Bai, Y., Chen, J.-Y., Hwang, T., Chen, T.-T., Chiu, H., & Li, Y. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04628yel · Cited by 46
Wampers, M., Hanssens, L., van Winkel, R., Heald, A. H., Collette, J., Peuskens, J., Reginster, J., Scheen, A. J., & Binder, M. D. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.03.010 · Cited by 46
Self-citationPrevalence of Metabolic Syndrome among Inpatients with Schizophrenia
Böke, Ö., Aker, S., Sarísoy, G., Saricicek, E. B., & Şahin, A. R. (2008) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.38.1.j · Cited by 46
Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics
Krane‐Gartiser, K., Breum, L., Glümer, C., Linneberg, A. R., Madsen, M., Køster, A., Jepsen, P. W., & Fink‐Jensen, A. (2011) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2011.565799 · Cited by 45
[Mortality in schizophrenic patients. 3 years follow-up of a cohort].
Casadebaig, F., & Philippe, A. (1999) · PubMed · Cited by 45
Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia
Morden, N. E., Lai, Z., Goodrich, D. E., MacKenzie, T., McCarthy, J. F., Austin, K., Welsh, D. E., Bartels, S., & Kilbourne, A. M. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.02.009 · Cited by 44
Khatana, S. A. M., Kane, J., Taveira, T. H., Bauer, M. S., & Wu, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019298 · Cited by 43
Yazici, M. K., Yağcioğlu, A. E. A., Ertugrul, A., Eni, N., Karahan, S., Karaağaoğlu, E., & Tokgozoglu, S. L. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0118-x · Cited by 40
Hanssens, L. S., VANWINKEL, R., Wampers, M., VANEYCK, D., Scheen, A. J., Reginster, J., Collette, J., Peuskens, J., & DEHERT, M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.008 · Cited by 40
Self-citationBinder, M. D., Mittoux, A., He, Y., & Peuskens, J. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0142-x · Cited by 39
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders
Koola, M. M., McMahon, R. P., Wehring, H. J., Liu, F., Mackowick, K. M., Warren, K. R., Feldman, S. M., Shim, J.-C., Love, R. C., & Kelly, D. L. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.04.019 · Cited by 39
Subashini, R., Deepa, M., Padmavati, R., THARA, R., & Mohan, V. (2011) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.90075 · Cited by 39
Bermudes, R. A., Keck, P. E., & Welge, J. A. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.6.491 · Cited by 38
Vuksan‐Ćusa, B., Šagud, M., & Jakovljević, M. (2010) · PubMed · Cited by 38
Meyer, J. M., Rosenblatt, L. C., Kim, E., Baker, R. A., & Whitehead, R. E. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04267 · Cited by 37
Metabolic syndrome among patients receiving clozapine: A preliminary estimate
Grover, S., Nebhinani, N., Chakrabarti, S., et al. (2011) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.84979 · Cited by 36
Attux, C. R. D. F., Quintana, M. I., & Chaves, A. C. (2007) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462006005000061 · Cited by 35
Diabetes mellitus in patients with schizophrenia in Taiwan
Hung, C., Wu, C.-K., & Lin, P. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.01.003 · Cited by 34
Baptista, T., Serrano, A., Uzcátegui, E., Fakih, Y. E., Rangel, N., Carrizo, E., Fernández, V., Connell, L., de Baptista, E. A., Quiroz, S., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.10.014 · Cited by 34
All-Cause Mortality and Medication Risk Factors in Schizophrenia
Tenback, D. E., Pijl, B. J., Smeets, H. M., van Os, J., & van Harten, P. N. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823f3c43 · Cited by 34
Maayan, L. A., & Vakhrusheva, J. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1097 · Cited by 30
Pallava, A., Chadda, R. K., Sood, M., & Ramakrishnan, L. (2011) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2011.621977 · Cited by 30
Kagal, U. A., Ss, T., Patil, N. M., et al. (2012) · Journal of Pharmacy Practice · doi:10.1177/0897190012442220 · Cited by 30
[The prevalence of metabolic syndrome and related factors in patients with schizophrenia].
Cerit, C., Özten, E., & Yıldız, M. (2008) · PubMed · Cited by 30
Grover, S., Nebhinani, N., Chakrabarti, S., Avasthi, A., Kulhara, P., Basu, D., Mattoo, S. K., & Malhotra, S. (2013) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2012.754052 · Cited by 29
Medved, V., Kuzman, M. R., Jovanović, N., Grubišin, J., & Kuzman, T. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093927 · Cited by 29
Shi, L., Ascher‐Svanum, H., Chiang, Y., Zhao, Y., Fonseca, V. A., & Winstead, D. K. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-80 · Cited by 28
Prevalence of Metabolic Syndrome among an Iranian Cohort of Inpatients with Schizophrenia
Rezaei, O., Ardakani, M. R. K., Mandegar, M. H., Dogmehchi, E., & Goodarzynejad, H. (2009) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.39.4.i · Cited by 27
Tirupati, S., & Chua, L.-E. (2007) · Australasian Psychiatry · doi:10.1080/10398560701636906 · Cited by 27
Diabetes, cardiovascular disease, and health care use in people with and without schizophrenia
Bresee, L. C., Majumdar, S. R., Patten, S. B., & Johnson, J. A. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2010.05.003 · Cited by 26
Lin, C.-C., Bai, Y., Wang, Y.-C., Chen, T., Lai, I., Chen, J., Chen, S., Gau, S. S., & Liou, Y. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181bf613e · Cited by 26
Zhang, R., Hao, W., Pan, M., Wang, C., Zhang, X., Chen, D. C., Xiu, M. H., Yang, F. D., Kosten, T. R., & Zhang, X. Y. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1220 · Cited by 25
Cheng, C., Chiu, H.-J., Loh, E., Chan, C.-H., Hwu, T.-M., Liu, Y., & Lan, T. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.10.011 · Cited by 25
Hert, M. D., Falissard, B., Mauri, M., Shaw, K. M., & Wetterling, T. (2008) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(08)70655-2 · Cited by 23
Na, K., Kim, W., Jung, H., Ryu, S. G., Min, K. J., Park, K.-C., Kim, Y.-S., Yoon, J., Ahn, Y. M., & Kim, C. E. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.024 · Cited by 21
Maslov, B., Marčinko, D., Milićević, R., Babić, D., Đorđević, V., & Jakovljević, M. (2009) · PubMed · Cited by 20
Ferreira, L., Belo, A., & Abreu‐Lima, C. (2010) · PubMed · Cited by 18
Cardiovascular risk factors in patients with first-episode psychosis in São Paulo, Brazil
Benseñor, I. M., Brunoni, A. R., Pilan, L. A., Goulart, A. C., Busatto, G. F., Lotufo, P. A., Scazufca, M., & Menezes, P. R. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2011.12.010 · Cited by 18
Lançon, C., Dassa, D., Fernandez, J., Richieri, R. M., Padovani, R., & Boyer, L. (2012) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2012/204043 · Cited by 17
Binder, M. D., Hanssens, L. S., Wampers, M., et al. (2007) · Schizophrenia Bulletin · Cited by 15
Self-citationBiochemical risk factors for development of obesity in first-episode schizophrenia
Bodén, R., Haenni, A., Lindström, L., & Sundström, J. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.09.024 · Cited by 14
Larsen, J. T., Fagerquist, M. V., Holdrup, M., Christensen, B., Sigalin, C., & Nilsson, P. M. (2010) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2010.486443 · Cited by 13
Vancampfort, D., Binder, M. D., Maurissen, K., Sweers, K., Knapen, J., Raepsaet, J., & Probst, M. (2011) · International Journal of Therapy and Rehabilitation · doi:10.12968/ijtr.2011.18.4.222 · Cited by 12
Self-citationCross-sectional prevalence of metabolic syndrome in Korean patients with schizophrenia
Kang, S. H., Kim, K. H., Kang, G. Y., Lee, K. H., Kim, K. K., Soh, M., Ahn, K. J., Kim, S. H., & Lee, J. I. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2010.12.014 · Cited by 11
Manu, P., Correll, C. U., Wampers, M., van Winkel, R., Yu, W., Mitchell, A. J., & Binder, M. D. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.05.002 · Cited by 10
Self-citationNurjono, M., & Lee, J. (2012) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2012.00384.x · Cited by 10
Mitchell, A. J., Vancampfort, D., Manu, P., Correll, C. U., Wampers, M., van Winkel, R., Yu, W., & Binder, M. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210674 · Cited by 9
Self-citationOtaño, L. M., Izquierdo, L. B., Mondragón, A. G., Pinedo, M. A., & Ayerdi, I. Q. (2012) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2012.04.010 · Cited by 8
Tras 6 meses de tratamiento antipsicótico: ¿mejoría de la salud mental a costa de la salud física?
Otaño, L. M., Izquierdo, L. B., Mondragón, A. G., Pinedo, M. A., & Ayerdi, I. Q. (2012) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2012.04.001 · Cited by 8
Basu, R., Thimmaiah, T. G., Chawla, J. M., Schlicht, P. J., Fagiolini, A. M., Brar, J. S., Khan, S. A., Challa, A., & Chengappa, K. N. R. (2009) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2009.08.006 · Cited by 6
Bisconer, S. W., & Harte, B. M. B. (2010) · Professional Psychology Research and Practice · doi:10.1037/a0018981 · Cited by 4
THE PREVALENCE OF METABOLIC SYNDROME IN SCHIZOPHRENIC PATIENTS IN THE NETHERLANDS
Schorr, S. G., Lucas, M. J. G., Slooff, C. J., et al. (2008) · Schizophrenia Research · doi:10.1016/s0920-9964(08)70726-6 · Cited by 4
Prevalence of Metabolic Syndrome in Schizophrenic Patients
Al-Hamzawi, A. O. (2015) · doi:10.13140/2.1.1342.5444 · Cited by 3
Cited by
Vancampfort, D., Stubbs, B., Mitchell, A. J., De Hert, M., Wampers, M., Ward, P. B., Rosenbaum, S., & Correll, C. U. (2015) · World Psychiatry · doi:10.1002/wps.20252 · Cited by 1,271
Self-citationCorrell, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015) · World Psychiatry · doi:10.1002/wps.20204 · Cited by 820
Self-citationVancampfort, D., Correll, C. U., Galling, B., Probst, M., De Hert, M., Ward, P. B., Rosenbaum, S., Gaughran, F., Lally, J., & Stubbs, B. (2016) · World Psychiatry · doi:10.1002/wps.20309 · Cited by 659
Self-citationA systematic review and meta-analysis of exercise interventions in schizophrenia patients
Firth, J., Cotter, J., Elliott, R., French, P., & Yung, A. R. (2015) · Psychological Medicine · doi:10.1017/s0033291714003110 · Cited by 600
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Metadata
- Authors
- Vancampfort, D., Wampers, M., Mitchell, A. J., Correll, C. U., De Herdt, A., Probst, M., & De Hert, M.
- Venue
- World Psychiatry
- Publisher
- Wiley
- Published
- 2013-10
- Volume
- 12
- Issue
- 3
- Pages
- 240-250
- ISSN
- 1723-8617 (ISSN-L)
- OpenAlex
- W2031913944
- Cited by
- 317
- References
- 176
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.